Articles tagged with "Drug Discovery"

Sort by

Aston-Warwick initiative wins key UKRI funds

February 11, 2024
A joint team from Aston and Warwick universities and the University of Warwick have won nearly £2 million in funding from UK Research and Innovation (UKRI).

Anglo-Norwegian study casts light on treatment resistant bacteria

February 4, 2024
A study comparing the UK and Norway over two decades, has concluded that antibiotic use may drive a rise in treatment-resistant bacteria but not in every instance.

Therapy ‘alters immune cells’ to fight unresponsive tumours

December 10, 2023
Finnish researchers say they have discovered how a new cancer therapy can alter the function of immune cells to enable them to infiltrate tumours previously unresponsive to treatment.

Aston mourns pharmacy school pioneer Mike Brown

December 4, 2023
Aston University Pharmacy School has announced the recent death of Professor Mike Brown, who was instrumental in building the reputation of the department.

Flower power inspires drug cell breakthrough

December 4, 2023
Bath university scientists have borrowed from nature to develop more stable versions of proteins and peptides for more effective pharmaceutical treatments.

Achieving an animal free IHC

November 13, 2023
With alternative technologies available, we should be seeking antibody alternatives that avoid the unnecessary use of animals in research, urges Dr David Bunka.

Genomics summit speaker calls for radical thinking to aid millions of rare disease patients

October 15, 2023
Hope is not lost for the thousands of individuals dealing with rare or undiagnosed diseases, urged Neil Ward, Vice President and General Manager EMEA for PacBio talking at the Genomics...

MRC £2 million targets hard to treat cancers

September 16, 2023
Cancers with notably poor survival rates are the targets of a £2 million Medical Research Council intervention to support researchers.

BDD wins £2 million investment to expand early phase clinical trials

August 20, 2023
Clinical trials company BDD has secured a further round of investment for £2 million to aid expansion of its patented drug delivery technology and specialist clinical trial services.

Pin It on Pinterest